Corebridge Financial »

Kymera Therapeutics shares owned by Corebridge Financial

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Corebridge Financial from 13F filings

Historical chart of Corebridge Financial investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Corebridge Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Corebridge Financial

Quarter filed Position value Share count Share price at filing
2025-03-31 $630k 23k 27.37
2024-12-31 $939k 23k 40.23

More positions owned by Corebridge Financial

Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Blackrock Etf Trust Ii Ishares Aaa Clo (CLOA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
Nrg Energy Com New (NRG)

View all positions for Corebridge Financial

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
venBio Select Advisor
FMR
BVF
Vanguard Group
Wellington Management Company
Atlas Venture Life Science Advisors
BlackRock
Siren
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Driehaus Capital Management
Ubs Global Asset Management Americas

View all funds holding Kymera Therapeutics